| Literature DB >> 24391743 |
Cuihong Xie1, Shabei Xu2, Fengfei Ding2, Minjie Xie2, Jiagao Lv3, Jihua Yao3, Dengji Pan2, Qian Sun2, Chenchen Liu2, Tie Chen4, Shusheng Li1, Wei Wang2.
Abstract
BACKGROUND: Massive wasp stings have been greatly underestimated and have not been systematically studied. The aim of this study was to identify the clinical features and treatment strategies of severe wasp stings. METHODS ANDEntities:
Mesh:
Substances:
Year: 2013 PMID: 24391743 PMCID: PMC3877022 DOI: 10.1371/journal.pone.0083164
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical characteristics of wasp sting patients.
| Age (years) | 42.5 (0.3–87.0) |
| Child(%) | 128 (11.7) |
| Adult (%) | 963 (88.7) |
| Sex (M∶F) | 620∶471 |
| Rural residence (%) | 897 (84.7) |
| Time elapse from bite to hospital (hours) | 10.7 (0.1–288.0) |
| Duration of hospital admission (days) | 3.8 (0.5–47.0) |
| Renal injury (%) | 183 (21.0) |
| Liver injury (%) | 230 (30.1) |
| Rhabdomyolysis (%) | 75 (24.1) |
| Hemolysis (%) | 177 (19.2) |
| Anuria/oliguria (%) | 83 (7.7) |
| Hemoglobinuria (%) | 110 (10.2) |
| Hypotension (%) | 49 (4.5) |
| Coagulopathy (%) | 88 (22. 5) |
| Pulmonary edema (%) | 84 (7.7) |
| Dialysis (%) | 119 (11.0) |
| Death (%) | 54 (5.1) |
1 <18 years of age.
2≥18 years of age.
Laboratory data of patients.
| No. of | No. of cases with abnormal | Mean of abnormal data | Range of | |
| Laboratory test(normal) | cases | data (%) | (±SD) | abnormal data |
| Hematology | ||||
| Hemoglobin (120–160 g/L) | 923 | 177(19.2) | 98.1(±17.8) | 19.0–119.0 |
| Platelets (100–300*109/L) | 923 | 85(9.2) | 73.3(±21.3) | 20.0–99.0 |
| Leukocytes (4–10*109/L) | 923 | 635(68.8) | 17.5(±7.0) | 10.1–51.2 |
| Neutrophils (50–75%) | 923 | 719(77.9) | 87.5 (±5.3) | 75.1–97.4 |
| Blood chemistry | ||||
| Creatinine (52–104 µmol/L) | 870 | 183(21.0) | 273.0 (±283.9) | 104.3–1829.7 |
| Blood urea nitrogen (2.3–7.1 mmol/L) | 870 | 241(27.7) | 14.4(±10.2) | 7.1–53.3 |
| Alanine aminotransferase (0–40 IU/L) | 765 | 230(30.1) | 399.4(±786.1) | 40.1–6995.0 |
| Aspartate aminotransferase (0–40 IU/L) | 765 | 343(44.8) | 769.5 (±1894.8) | 40.1–14862.0 |
| Serum total bilirubin (3.4–17.1 mmol/L) | 765 | 360(47.1) | 55.3 (±66.3) | 17.2–479.5 |
| Serum conjugated bilirubin (0–6.8 mmol/L) | 765 | 269(35.2) | 24.2 (±36.4) | 6.9–265.4 |
| Creatine kinase (0–195 IU/L) | 311 | 164(52.7) | 6536.3(±12031.6) | 198.0–74844.0 |
| Lactate dehydrogenase (0–235 IU/L) | 296 | 152(51.4) | 2084.6(±2859.5) | 246.0–14098.0 |
| Glycemia (3.9–6.1 mmol/L) | 555 | 250(45.1) | 10.8(±3.4) | 7.8–30.1 |
| Blood coagulation test | ||||
| Prothrombin time (11–14.5 s) | 392 | 135(34.4) | 18.1(±6.3) | 14.6–62.9 |
| Activated partial prothrombin time (32–45 s) | 392 | 148(37.8) | 94.6(±52.0) | 45.2–290.4 |
| Urine test | ||||
| Qualitative proteinuria(negtive) | 596 | 90(15.1) | ||
| Qualitative hematuria(negtive) | 596 | 146(24.5) | ||
| Flow cytometry analysis | ||||
| IL-6 (5 pg/ml) | 25 | 17(68.0) | 28.1(±37. 6) | 5.6–149.5 |
| Regulatory T lymphocyte (CD3+CD4+CD25+CD27low+)(4.59–7.81%) | 25 | 21(84.0) | 1.6(±1.0) | 0.2–3.4 |
| Natural regulatory T lymphocyte (CD45RA+CD3+CD4+CD25+CD27low+)(2.07–4.55%) | 25 | 21(84.0) | 0.3(±0.3) | 0–0.9 |
Relationship between number of wasp stings and clinical presentation/outcome.
| No. of envenomation | ≤10 | >10 | P value |
| No. of patients | 197 | 657 | |
| Deaths (%) | 2/196(1.0%) | 33/638(5.2%) | 0.02 |
| Elevated creatinine (%) | 16/124(12.9%) | 116/552(21.0%) | 0.039 |
| Elevated BUN (%) | 21/124(16.9%) | 128/552(23.2%) | 0.129 |
| Descended HGB (%) | 13/144(9.0%) | 122/578(21.1%) | 0.001 |
| Elevated ALT (%) | 14/104(13.5%) | 156/490(31.8%) | <0.001 |
| Elevated AST (%) | 27/104(26.0%) | 223/490(45.5%) | <0.001 |
| Elevated CK (%) | 10/35(28.6%) | 119/212(56.1%) | 0.002 |
| Elevated LDH (%) | 12/31(38.7%) | 102/197(51. 8%) | 0.176 |
| Extended PT (%) | 11/78(14.1%) | 82/314(26.1%) | 0.026 |
| Extended APTT (%) | 17/78(21.8%) | 113/314(36.0%) | 0.017 |
Comparison of clinical features of venom-specific IgE(+) and venom-specific IgE(−) patients.
| Stings | Anaphylactic shock | Apnea | Nausea and vomiting | Oliguria | Hemoglobinuria | Cr/BUN level elevation | Hepatic dysfunction | CK level elevation | |||
| 10–20 | 20–50 | >50 | |||||||||
| sIgE(+) patients | 37.5%(6/16) | 56.3%(9/16) | 6.3%(1/16) |
| 6.3%(1/16) | 100%(16/16) | 81.3%(13/16) | 62.5%(10/16) | 87.5%(14/16) | 87.5%(14/16) | 75.0%(12/16) |
| sIgE(−) patients | 22.2%(2/9) | 66.7%(6/9) | 11.1%(1/9) |
|
| 100%(9/9) | 100%(9/9) | 100%(9/9) | 100%(9/9) | 100%(9/9) | 100%(9/9) |
None of sIgE(+) or sIgE(−) patients present with this clinical feature.